Adolfo Garcia-Sastre | sciencenewsnet.in

Breaking News

Kansas Proving Grounds Partners with SkyScoutAI Innovations Inc. to Deploy AI-Powered Drones for Wildfire Solution at America’s First Carbon Neutral Industrial Park

Perinatal Transmission of HIV Can Lead to Cognitive Deficits

CSUF Grad from Zimbabwe Aims to Improve Access to Mental Health Services

Alzheimer’s Consortium set to bring experts and families together at ASU

Critical Minerals Recovery from Electronic Waste

The Pediatric Emergency Department at Joseph M. Sanzari Children’s Hospital Becomes the First Autism Certified Center in the State

Genetics predict type 2 diabetes risk and disparities in childhood cancer survivors

Landmark Conference Celebrating Betty Ford’s Legacy as First Lady, With Notable Expert Panels

New study points to racial and social barriers that block treatment for multiple myeloma

Artificial Intelligence Can Evaluate Cardiovascular Risk During CT Scan

24 Apr, 2024

Mount Sinai Researchers Awarded $16 Million to Develop Antivirals Against Viruses With Pandemic Potential

June 1, 2022 sarah JonasAnnouncement

Researchers at the Icahn School of Medicine at Mount Sinai have been awarded an initial $16 million from the National Institutes of Health (NIH) to discover and develop globally accessible and affordable novel oral antivirals to combat COVID-19 and future pandemics.